Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Autoimmune Disorders

  Free Subscription


30.05.2022

1 Am J Kidney Dis
1 Brain
7 Diabetes Res Clin Pract
2 J Neuroimmunol
12 J Neurol
2 Kidney Int
8 Mult Scler
1 Neurologia (Engl Ed)
2 Neurology
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Kidney Dis

  1. LIANG KV, Ellis BK, Stokes MB, Smith RJ, et al
    Hematuria and Proteinuria in a Patient With Recurrent Pulmonary Illnesses: A Quiz.
    Am J Kidney Dis. 2022;79:A13-A15.
    PubMed        


    Brain

  2. GUO Y, Lennon VA, Parisi JE, Popescu B, et al
    Spectrum of sublytic astrocytopathy in neuromyelitis optica.
    Brain. 2022;145:1379-1390.
    PubMed         Abstract available


    Diabetes Res Clin Pract

  3. KIMBELL B, Rankin D, Hart RI, Allen JM, et al
    Parents' experiences of using a hybrid closed-loop system (CamAPS FX) to care for a very young child with type 1 diabetes: Qualitative study.
    Diabetes Res Clin Pract. 2022;187:109877.
    PubMed         Abstract available

  4. NETTLETON JA, Burton AE, Povey RC
    "No-one realises what we go through as Type 1s": A qualitative photo-elicitation study on coping with diabetes.
    Diabetes Res Clin Pract. 2022;187:109876.
    PubMed         Abstract available

  5. GUO J, Liu C, Pan J, Yang J, et al
    Relationship between diabetes and risk of gastric cancer: A systematic review and meta-analysis of cohort studies.
    Diabetes Res Clin Pract. 2022;187:109866.
    PubMed         Abstract available

  6. MAY NG S, Malene IV, Nilar M, Rassavong K, et al
    Closing the Type 1 Diabetes gap in South-East Asia through government partnership working with non-government organisations.
    Diabetes Res Clin Pract. 2022;187:109868.
    PubMed         Abstract available

  7. PRAVEEN PA, Anandakumar A, Singh K, Prabhakaran D, et al
    Cardiovascular disease risk profile of Indian young adults with type 1 diabetes compared to general population - A sub-study from the Young Diabetes Registry (YDR), India.
    Diabetes Res Clin Pract. 2022;187:109863.
    PubMed         Abstract available

  8. KULZER B, Freckmann G, Heinemann L, Schnell O, et al
    Patch Pumps: What are the advantages for people with diabetes?
    Diabetes Res Clin Pract. 2022;187:109858.
    PubMed         Abstract available

  9. WANG Z, James-Todd TM, Isganaitis E, O'Connell J, et al
    Associations of insulin pump and continuous glucose monitoring use with pregnancy-related outcomes in women with type 1 diabetes.
    Diabetes Res Clin Pract. 2022;187:109854.
    PubMed         Abstract available


    J Neuroimmunol

  10. KLEIN CJ, Beecher G, Lamb C, Naddaf E, et al
    LRP4-IgG service line testing in seronegative myasthenia gravis and controls.
    J Neuroimmunol. 2022;368:577895.
    PubMed         Abstract available

  11. YAO Y, Uddin MN, Manley K, Lawrence DA, et al
    Improvements of autism-like behaviors but limited effects on immune cell metabolism after mitochondrial replacement in BTBR T(+)Itpr3(tf)/J mice.
    J Neuroimmunol. 2022;368:577893.
    PubMed         Abstract available


    J Neurol

  12. ZIEMSSEN T, Lang M, Schmidt S, Albrecht H, et al
    Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany.
    J Neurol. 2022;269:3276-3285.
    PubMed         Abstract available

  13. AKAISHI T, Misu T, Fujihara K, Takahashi T, et al
    Relapse activity in the chronic phase of anti-myelin-oligodendrocyte glycoprotein antibody-associated disease.
    J Neurol. 2022;269:3136-3146.
    PubMed         Abstract available

  14. DI SABATINO E, Gaetani L, Sperandei S, Fiacca A, et al
    The no evidence of disease activity (NEDA) concept in MS: impact of spinal cord MRI.
    J Neurol. 2022;269:3129-3135.
    PubMed         Abstract available

  15. WILLISON AG, Ruck T, Lenz G, Hartung HP, et al
    Correction to: The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis.
    J Neurol. 2022 May 24. pii: 10.1007/s00415-022-11158.
    PubMed        

  16. FILIPPI M, Amato MP, Centonze D, Gallo P, et al
    Early use of high-efficacy diseasemodifying therapies makes the difference in people with multiple sclerosis: an expert opinion.
    J Neurol. 2022 May 24. pii: 10.1007/s00415-022-11193.
    PubMed         Abstract available

  17. BATTAGLIA MA, Bezzini D, Cecchini I, Cordioli C, et al
    Patients with multiple sclerosis: a burden and cost of illness study.
    J Neurol. 2022 May 23. pii: 10.1007/s00415-022-11169.
    PubMed         Abstract available

  18. VAN ROSMALEN MHJ, Froeling M, Mandija S, Hendrikse J, et al
    MRI of the intraspinal nerve roots in patients with chronic inflammatory neuropathies: abnormalities correlate with clinical phenotypes.
    J Neurol. 2022;269:3159-3166.
    PubMed         Abstract available

  19. AYVACIOGLU CAGAN C, Temucin CM, Arslan D, Gocmen R, et al
    Isolated spinal cord granulomatous angiitis: a case report and review of the literature.
    J Neurol. 2022;269:3175-3179.
    PubMed         Abstract available

  20. JENTZER A, Carra-Dalliere C, Lozano C, Riviere S, et al
    Neuromyelitis optica spectrum disorder following COVID-19 infection with increase in pre-existing anti-aquaporin-4 antibodies.
    J Neurol. 2022;269:2850-2853.
    PubMed        

  21. LAMBERT N, Lutteri L, Tshibanda L, Bianchi E, et al
    Anti-SOX1 antibody-associated acute hemorrhagic leukoencephalitis.
    J Neurol. 2022;269:3359-3362.
    PubMed        

  22. YOGANATHAN K, Stevenson A, Tahir A, Sadler R, et al
    Bedside and laboratory diagnostic testing in myasthenia.
    J Neurol. 2022;269:3372-3384.
    PubMed         Abstract available

  23. ARINO H, Heartshorne R, Michael BD, Nicholson TR, et al
    Neuroimmune disorders in COVID-19.
    J Neurol. 2022;269:2827-2839.
    PubMed         Abstract available


    Kidney Int

  24. LODI L, Mastrolia MV, Bello F, Rossi GM, et al
    Type I interferon-related kidney disorders.
    Kidney Int. 2022;101:1142-1159.
    PubMed         Abstract available

  25. MISRA DP, Agarwal V
    Management of refractory lupus nephritis: rationale to consider tacrolimus.
    Kidney Int. 2022;101:1293.
    PubMed        


    Mult Scler

  26. DAMS L, Kraemer M, Becker J
    MOG-antibody-associated longitudinal extensive myelitis after ChAdOx1 nCoV-19 vaccination.
    Mult Scler. 2022;28:1159-1162.
    PubMed         Abstract available

  27. WRIGHT S
    MOG antibody-associated longitudinal extensive myelitis after Oxford-Astra Zeneca's COVID-19 vaccination.
    Mult Scler. 2022;28:1163.
    PubMed        

  28. RINALDI V, Bellucci G, Romano A, Bozzao A, et al
    ADEM after ChAdOx1 nCoV-19 vaccine: A case report.
    Mult Scler. 2022;28:1151-1154.
    PubMed         Abstract available

  29. PODDA J, Tacchino A, Pedulla L, Monti Bragadin M, et al
    Focus on neglected features of cognitive rehabilitation in MS: Setting and mode of the treatment.
    Mult Scler. 2022;28:1009-1019.
    PubMed         Abstract available

  30. MATEEN FJ
    Low-dose rituximab should be used for treating MS in resource-limited settings: No.
    Mult Scler. 2022;28:1030-1032.
    PubMed        

  31. PIEHL F, Mathew T
    Low-dose rituximab should be used for treating MS in resource-limited settings: Yes.
    Mult Scler. 2022;28:1028-1029.
    PubMed        

  32. CARCAMO C, Ciampi E
    Low-dose rituximab should be used for treating MS in resource-limited settings: Commentary.
    Mult Scler. 2022;28:1032-1033.
    PubMed        

  33. COFRE LIZAMA LE, Strik M, Van der Walt A, Kilpatrick TJ, et al
    Gait stability reflects motor tracts damage at early stages of multiple sclerosis.
    Mult Scler. 2022 May 21:13524585221094464. doi: 10.1177/13524585221094464.
    PubMed         Abstract available


    Neurologia (Engl Ed)

  34. RODRIGUEZ-MONTOLIO J, Ballesta-Martinez S, Martin-Aleman Y, Munoz-Farjas E, et al
    Acute disseminated encephalomyelitis after Mycoplasma pneumoniae infection: unfavourable clinical course, excellent recovery.
    Neurologia (Engl Ed). 2022;37:313-315.
    PubMed        


    Neurology

  35. SOTIRCHOS ES, Vasileiou ES, Filippatou AG, Fitzgerald KC, et al
    Association of Serum Neurofilament Light Chain With Inner Retinal Layer Thinning in Multiple Sclerosis.
    Neurology. 2022 May 26. pii: WNL.0000000000200778.
    PubMed         Abstract available

  36. GRAVES J
    Identifying Multiple Sclerosis Activity: Do the Eyes Have It?
    Neurology. 2022 May 26. pii: WNL.0000000000200903.
    PubMed        


    PLoS One

  37. KIBIRIGE D, Sekitoleko I, Balungi P, Kyosiimire-Lugemwa J, et al
    Islet autoantibody positivity in an adult population with recently diagnosed diabetes in Uganda.
    PLoS One. 2022;17:e0268783.
    PubMed         Abstract available

  38. SHEU NW, Huang SH, Wu DC, Kao JY, et al
    Effects of Helicobacter pylori treatment on the incidences of autoimmune diseases and inflammatory bowel disease in patients with diabetes mellitus.
    PLoS One. 2022;17:e0265323.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: